scispace - formally typeset
A

Arnold J. Levine

Researcher at Institute for Advanced Study

Publications -  493
Citations -  122094

Arnold J. Levine is an academic researcher from Institute for Advanced Study. The author has contributed to research in topics: Gene & Mutant. The author has an hindex of 139, co-authored 485 publications receiving 116005 citations. Previous affiliations of Arnold J. Levine include Harvard University & Affymetrix.

Papers
More filters
Patent

A Lac REPRESSOR-HSV VP16 CHIMERIC TRANSCRIPTIONAL ACTIVATOR PROTEIN SYSTEM FUNCTIONING IN TRANSFECTED MAMMALIAN CELLS

TL;DR: The chimeric transactivating proteins of as discussed by the authors offer a variety of advantages, including the specific activation of expression of genes engineered to comprise transactivator responsive elements, thereby achieving exceptionally high levels of gene expression.
Journal ArticleDOI

Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas.

TL;DR: The NZW mice appear to contribute a dominant negative regulator for the expression of the SV40 large T antigen transgene, which in turn has a dramatic effect upon the time of appearance of tumors and the death of these transgenic animals.
Book ChapterDOI

The SV40 Large Tumor Antigen

TL;DR: This review brings together a large number of observations and facts that have been assembled during the study of the large tumor antigen protein (T antigen) encoded by simian virus 40 (SV40).
Journal ArticleDOI

PCA and clustering reveal alternate mtDNA phylogeny of N and M clades.

TL;DR: The tree recreates the standard phylogeny of the N, M, L0/L1, L2, and L3 clades, confirming the African origin of modern humans and showing that the M and N clades arose in almost coincident migrations.
Patent

Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator protein

TL;DR: The chimeric transactivating proteins of as discussed by the authors offer a variety of advantages, including the specific activation of expression of genes engineered to comprise transactivator responsive elements, thereby achieving exceptionally high levels of gene expression.